Likarda is a biotechnology company focused on developing innovative cell therapies and delivery technologies. Utilizing its patented Core-Shell Spherification® platform, Likarda specializes in cell encapsulation within biocompatible hydrogels, such as Hyaluronic Acid and PEG, which allows for customized delivery solutions tailored to the unique specifications of various cell therapies. The company's approach enables the creation of microcapsules that can provide injectable treatments with enhanced localization and efficacy or offer immunoprotective barriers for long-term cell transplants. Likarda is actively working on therapies for diabetes and osteoarthritis, including the delivery of islet-like cells for diabetes treatment and the slow-release injection of encapsulated stem cells for alleviating joint pain and reversing osteoarthritis degradation. The company has achieved significant recognition, including being named one of the "50 Most Promising Start-Ups in the World." To date, Likarda has secured over $8 million in funding through private investments, grants, and contract services.
Synvect is a biotech platform that creates safe and effective ways to eliminate disease-carrying mosquitoes by stopping their breeding.
SeamlessHR Limited is a human resource technology software company based in Lagos, Nigeria, founded in 2013. It offers a comprehensive, cloud-based HR platform tailored for medium to large-sized organizations, facilitating the automation and optimization of HR processes from recruitment to retirement. The company's product suite includes a Recruitment Management System, HR Management System, Learning Management System, Payroll Management, Leave Management, and Performance and Competency Management tools. Additionally, SeamlessHR provides HR analytics and embedded finance solutions aimed at enhancing financial security for both employers and employees. Through its technology, SeamlessHR enables businesses to streamline various HR functions, ensuring efficient management of their workforce.
The Independent is a global news organization that delivers news, commentary, and analysis aimed at an independently-minded audience. It operates a weekly newspaper that covers a wide range of topics, including sports, business, fashion, lifestyle, real estate, entertainment, and local news. Alongside its print operations, The Independent utilizes its website and mobile apps to provide readers with current affairs and investigative reporting, ensuring comprehensive coverage of significant incidents worldwide. In addition to news articles, the publication also offers classified ads and horoscopes, catering to diverse reader interests and maintaining its position as a prominent newsbrand.
ReciBioPharm operates as a biologics company. ReciBioPharm is a division of Recipharm.
Micron Biomedical is a clinical-stage biopharmaceutical company established in 2014 and located in Atlanta, Georgia. The company focuses on developing microneedle patches specifically for vaccines, including those for influenza and polio. Its innovative microneedle technology aims to improve protective and therapeutic effects while enhancing patient compliance and simplifying the administration process. By leveraging this technology, Micron Biomedical seeks to facilitate the development of effective vaccines, addressing important public health needs.
Aptitude Medical Systems provides the next generation of diagnostic testing, delivering lab-quality results quickly and easily wherever people need them. The company's mission is to combine the sensitivity and specificity of lab-based PCR tests with the cost-effectiveness and scalability of antigen tests. The company has developed proprietary synthetic molecules, known as aptamers, which enhance molecular recognition capabilities beyond traditional antibody technologies. This innovation enables early detection and treatment of diseases such as cancer, autoimmune disorders, and heart disease.
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Avanti Platform is an open-access digital financial spine, flexible enough for users and partners to create, curate and deploy the financial products
WindBorne Systems Inc., founded in 2019 and based in Stanford, California, specializes in developing and operating a network of smart weather balloons for atmospheric data collection. The company utilizes high-altitude balloons equipped with advanced sensors to gather precise measurements from various layers of the atmosphere. This data is crucial for weather forecasting, climate research, and environmental monitoring, allowing for more accurate predictions and better preparedness for severe weather events. WindBorne Systems distributes its information to both government and private weather services, contributing to efforts aimed at mitigating the impacts of climate change and improving overall understanding of climatic conditions, even in previously inaccessible regions.
VitriVax is a biotechnology startup based in Boulder, Colorado, focused on developing an innovative vaccine formulation platform. The company utilizes its proprietary atomic layering thermostable antigen and adjuvant (ALTA) technology to create vaccines that are more effective, affordable, and accessible worldwide. This technology addresses the challenges associated with vaccine stability and administration by enabling the development of thermostable, single-shot vaccines that can effectively incorporate both prime and booster doses. VitriVax's advancements in vaccine formulation aim to eliminate barriers to global vaccination, ultimately enhancing immune responses for a broad range of medical indications. The company has received significant funding, including over $5 million from various sources such as the National Institutes of Health, the National Science Foundation, and the Bill and Melinda Gates Foundation, to support its mission.
Magma Math is an e-learning math platform for K–12 classrooms that helps improve teaching practises and learning for students.
BioSurfaces is a provider of medical care services intended to be offered by augmenting existing and emerging medical approaches with nanotechnology. The company's services applies room-temperature electrospinning process to allow drug loading into each fiber, providing a reservoir for sustained drug release at the implant site, enabling customers to make devices and coatings as thin as 10um which can treat diseases at site.
Freya Biosciences is a clinical-stage company focused on women's health, with operations in Copenhagen and Boston. It specializes in developing microbial immunotherapies aimed at addressing significant unmet medical needs across various conditions. The company utilizes a proprietary platform to engineer and manufacture live microbes, ensuring their safety and efficacy for human use. Through this innovative approach, Freya Biosciences seeks to create new treatment options for a range of diseases, striving to make a meaningful impact in the healthcare sector.
Based in the vibrant Phoenix Metro Area and supported by a global team, Canyon GBS® is a pioneering tech company crafting impactful solutions powered by AI. With a diverse range of offerings tailored for sectors such as higher education, public sector government agencies, non-profits, and small businesses, Canyon GBS® is dedicated to enhancing operational efficiency. Our mission is to equip organizations with powerful yet accessible AI-powered technology to better serve their constituents. Through our relentless pursuit of innovation and customer-centric approach, Canyon GBS® strives to be a trusted partner in navigating today's digital landscape.
La Ruche Health provides an innovative platform that connects patients with virtual and at-home healthcare services. Utilizing health AI technology, it offers advice and facilitates the booking of medical services and lab tests through user-friendly applications on iOS, Android, and WhatsApp. The company has recognized WhatsApp as a key distribution channel, being the first to integrate generative AI into this platform to enhance conversational experiences, particularly for low-literacy communities. Additionally, La Ruche Health develops a medical record management system that enables healthcare teams to efficiently manage and exchange medical data through both web and mobile applications. This comprehensive platform allows for virtual and physical consultations, as well as access to a wellness marketplace designed to make modern health services more affordable and accessible to various communities.
PopVax is a biotechnology company that developing novel mRNA vaccines and therapeutics using computational protein design.
ApiJect Systems is a medical technology company focused on revolutionizing the delivery of injectable medications through its innovative platform for prefilled, single-dose injectors. By utilizing medical-grade plastic resin, ApiJect replaces traditional materials like glass and rubber, streamlining the manufacturing process and significantly reducing environmental impact. The ApiJect Platform enables pharmaceutical and biotech companies to efficiently produce scalable prefilled injectors, either on proprietary Blow-Fill-Seal packaging lines or through partnerships with other manufacturers. This approach not only simplifies the supply chain but also accelerates production times, transforming a multi-step process that typically takes weeks into a rapid, efficient operation. Through these advancements, ApiJect aims to make prefilled injections more affordable and accessible to patients globally.
Stellapps designs dairy management software applications that leverage the power of technology to improve dairy supply chain parameters. The company's applications leverage the Internet of Things (IoT), big data, cloud, mobility and data analytics to improve agri-supply chain parameters, including milk production, milk procurement, cold chain animal insurance and farmer payments, enabling dairy farms, dairy farmers and cooperatives to maximize profits while minimizing effort.
AN2 Therapeutics, Inc. is a biopharmaceutical company based in Menlo Park, California, founded in 2017. The company is dedicated to the research, development, and commercialization of innovative medicines aimed at addressing infectious diseases. AN2 Therapeutics is focused on developing epetraborole, a once-daily oral treatment for patients suffering from chronic non-tuberculous mycobacterial lung disease, which represents a significant unmet medical need. Additionally, the company has established a strategic partnership with Brii Biosciences to enhance its development efforts.
CanSino Biologics focuses on the R&D, manufacturing, and commercialization of vaccine products for human use. These vaccine products include pneumococcal polysaccharide and conjugate vaccines, and a DTcP-based combo, and other items. It is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine.
Chemify is a developer of a chemical digitization platform that integrates automated synthetic hardware with a unique chemical programming language. This platform allows for the on-demand conversion of digital code into molecules, facilitating drug and materials discovery as well as chemical synthesis. Chemify's system is designed to be modular, universal, scalable, and teachable, making it suitable for various applications in chemical and material research. The software incorporates natural language processing to translate synthetic procedures and features a comprehensive ontology, which aids users in creating chemical processes while providing insights into reaction conditions and identifying potential issues. This capability enables scientists to access detailed real-time telemetry of chemical reactions, enhancing efficiency and accuracy in their work.
Radiant Biotherapeutics is an innovative company focused on developing a modular platform for multi-valent and multi-specific therapeutics. This platform aims to advance antibody engineering by producing multi-functional biologics capable of addressing challenging diseases, including cancer, autoimmune disorders, and infectious diseases. By leveraging enhanced binding power and multi-specificity, Radiant Biotherapeutics seeks to create potent therapeutics that have the potential to significantly improve treatment outcomes for patients. The company is committed to delivering transformative therapies through its cutting-edge approach to antibody technology.
Eyam Vaccines and Immunotherapeutics is a life science company focused on the research and development of vaccines aimed at combating infectious diseases. The company specializes in creating vaccines that target the spike glycoprotein protein, which generates neutralizing antibodies against the novel coronavirus. Eyam utilizes a self-amplifying vaccine platform designed to produce low-dose vaccines that offer advanced targeting capabilities for broad coverage and protection, addressing both current and emerging variants. By prioritizing the development of innovative vaccine solutions, Eyam aims to meet critical healthcare needs in the face of evolving infectious threats.
Field develops technology aimed at enhancing pharmaceutical supply chains, enabling governments and businesses to deliver healthcare more effectively in rapidly growing regions. The company's platform focuses on digitizing and modernizing supply chain processes, making them easier to use and more scalable. By partnering with communities, Field aims to strengthen and sustain these vital supply chains, ultimately improving access to healthcare for millions of people globally.
Upsolve helps low-income Americans get a fresh start after sudden financial shocks by automating bankruptcy. It provides a free online tool that asks users questions and generates a Chapter 7 bankruptcy forms, after that, the company's lawyers will review the forms.Jonathan Petts and Rohan Pavuluri founded Upsolve in June 2016, with its headquarters in New York City.
Propel, Inc. is a technology company based in Brooklyn, New York, founded in 2014. It specializes in developing mobile software applications aimed at improving the financial health of low-income Americans. The company's primary product, Providers, is a free app designed for EBT cardholders, enabling them to manage their government benefits, such as SNAP and rental assistance. The app also helps users save on essential expenses and earn cash, while offering features that allow them to check their balance and organize budgets around local deals. Propel's focus is on empowering its users to better navigate financial challenges and enhance their economic well-being.
Legume Technology is a producer of organic, contaminant-free, biostimulant products that are proven to increase yield. They provide services such as physicochemical improvement of pellets, compatibility testing, coating machinery, private labelling, marketing support, registration support from legume technology, pre-treatment inoculant training, application strategy and techniques. Their products like liquifix, liquifix 120, legumefix, molyfix, rootfix, extensive,and mycofix. They provide support for crops such as soya, peas, lupin, lucerne, wheat, chickpeas, clover, corn, and sunflower.
Immorna is a biotechnology company focused on developing RNA-based therapeutics and vaccines. The company employs various RNA platforms, including conventional, self-replicating, and circular RNA, to create innovative treatments. Immorna has established a comprehensive central management console for RNA synthesis, purification, and analytical testing, which facilitates both clinical and commercial development. Additionally, the company has developed advanced screening tools and a range of RNA delivery vehicles, such as polymers and lipid nanoparticles, incorporating proprietary ionizable cationic lipids. This robust infrastructure positions Immorna to contribute significantly to the field of RNA therapeutics.
Noze is a leader in digital odor perception technology, creating advanced solutions that replicate the human sense of smell. Their sophisticated digital nose utilizes a specialized sensor, developed with NASA technology, to detect and identify odors in various real-world environments. This technology collects and analyzes data through an AI engine, allowing healthcare providers to assess air quality, monitor chemical footprints, and potentially diagnose diseases based on breath-based odor biomarkers. By enabling real-time disease detection and routine health screenings with a single exhale, Noze aims to enhance human health and well-being while improving patient outcomes.
RiseKit, Inc. is a Chicago-based company that provides software aimed at connecting entry to mid-level job candidates, particularly from underserved communities, with employment opportunities, training programs, and supportive services. Founded in 2016, RiseKit addresses employment barriers by ensuring that job seekers have access to career paths regardless of their geographic or socio-economic circumstances. The company serves a diverse clientele, including nonprofits, government agencies, and employers, helping them efficiently support job candidates and measure outcomes. By facilitating connections between untapped talent and organizations looking to hire, RiseKit not only empowers individuals to overcome obstacles to employment but also assists community partners in enhancing their capabilities through scalable software solutions.
Snipr Biome ApS is a biotechnology company based in Copenhagen, Denmark, focusing on the development of CRISPR technology for the treatment of microbial diseases. Established in 2017, the company aims to revolutionize how such diseases are addressed by leveraging the adaptive immune system to create medicines that selectively target and eliminate harmful bacteria based on their specific DNA sequences. By utilizing a novel approach that subverts elements of the endogenous bacterial CRISPR machinery, Snipr Biome provides health professionals with innovative tools for targeted microbiome engineering, enhancing the precision and effectiveness of treatments for bacterial infections.
ETHRIS develops mRNA therapeutics with a focus on respiratory diseases and vaccines. ETHRIS possesses an enabling LNP delivery and mRNA modification platform for transcript Therapies. SNIM®RNAis a first-in-class biopharmaceutical which provide a compelling alternative for recombinant protein or gene therapies. SNIM®RNAs encode therapeutic proteins to be produced in the patient‘s body and overcome short duration effects of recombinant proteins. SNIM®RNA Transcript Therapy is a new option for a broad variety of diseases, either acquired or genetically predetermined, lifestyle- or age-related, rare or frequent.
The Alan Turing Institute is the national institute for data science. The Institute is named in honour of Alan Turing (23 June 1912 – 7 June 1954), whose pioneering work in theoretical and applied mathematics, engineering and computing are considered to be the key disciplines comprising the emerging field of data science.
Ben-Gurion University of the Negev is one of Israel’s leading research universities and among the world leaders in many fields. It has around 20,000 students and 4,000 faculty members in the Faculties of Engineering Sciences; Health Sciences; Natural Sciences; the Pinchas Sapir Faculty of Humanities and Social Sciences; the Guilford Glazer Faculty of Business and Management; the Joyce and Irving Goldman School of Medicine; the Kreitman School of Advanced Graduate Studies; and the Albert Katz International School for Desert Studies. More than 100,000 alumni play important roles in all areas of research and development, industry, health care, the economy, society, culture and education in Israel. The University has three main campuses: The Marcus Family Campus in Beer-Sheva; the research campus at Sede Boqer and the Eilat Campus, and is home to national and multi-disciplinary research institutes: the National Institute for Biotechnology in the Negev; the National Institute of Solar Energy; the Ilse Katz Institute for Nanoscale Science and Technology; the Jacob Blaustein Institutes for Desert Research; the Ben-Gurion Research Institute for the Study of Israel & Zionism, and Heksherim - The Research Institute for Jewish and Israeli Literature and Culture.
Shomvob is an integrated fintech and HR-tech platform designed to serve the emerging frontline workforce in Bangladesh. The platform focuses on creating job opportunities by assisting individuals in developing a digital professional identity and expanding their professional networks. By aligning job offerings with users' skills, qualifications, and expectations, Shomvob enhances employment prospects. Additionally, the company promotes financial inclusion through a comprehensive payroll financing product, further supporting the workforce in accessing essential financial services.
Nanite is a biotechnology company focused on non-viral gene delivery through the development of programmable polymer nanoparticles. Utilizing an artificial intelligence-driven platform, Nanite combines advanced high-throughput experimental and computational methods to create tailored delivery vehicles. These vehicles are designed to effectively transport a wide range of genetic materials with specific targeting capabilities, facilitating research in functional chemistry and enhancing the design of therapeutically relevant gene delivery systems.
Surf Bio is a preclinical biopharmaceutical company leveraging a breakthrough next-generation surfactant to develop enhanced therapeutic solutions for diabetes, oncology, infectious diseases, gene therapy, and other therapeutic areas.
Owlstone Medical Ltd is a diagnostics company based in Cambridge, United Kingdom, specializing in non-invasive breath-based diagnostic tools aimed at the early detection of diseases, including cancer and respiratory conditions. The company develops a range of innovative products, including its Breath Biopsy platform, which utilizes advanced technology to identify volatile organic compounds in breath samples. Its offerings include FAIMS technology for medical applications, Lonestar for disease biomarker detection, and ReCIVA breath samplers for in vitro analysis. Owlstone Medical's technology has significant applications in various medical fields, such as lung cancer, bowel cancer, and gastrointestinal disorders. The company is also exploring the development of a portable hand-held device that promises high sensitivity and selectivity for chemical detection, with potential applications across multiple markets, including military and industrial sectors. Owlstone Medical aims to become a leader in non-invasive diagnostics, with ongoing collaborations and trials, including contracts with the UK National Health Service for lung cancer screening initiatives.
Owlstone Medical Ltd is a diagnostics company based in Cambridge, United Kingdom, specializing in non-invasive breath-based diagnostic tools aimed at the early detection of diseases, including cancer and respiratory conditions. The company develops a range of innovative products, including its Breath Biopsy platform, which utilizes advanced technology to identify volatile organic compounds in breath samples. Its offerings include FAIMS technology for medical applications, Lonestar for disease biomarker detection, and ReCIVA breath samplers for in vitro analysis. Owlstone Medical's technology has significant applications in various medical fields, such as lung cancer, bowel cancer, and gastrointestinal disorders. The company is also exploring the development of a portable hand-held device that promises high sensitivity and selectivity for chemical detection, with potential applications across multiple markets, including military and industrial sectors. Owlstone Medical aims to become a leader in non-invasive diagnostics, with ongoing collaborations and trials, including contracts with the UK National Health Service for lung cancer screening initiatives.
Sibel Health focuses on developing advanced monitoring solutions that enhance healthcare delivery and improve patient outcomes through wireless vital signs monitoring and data integration. The company creates soft, flexible sensors capable of measuring critical parameters such as heart rate, respiratory rate, skin temperature, body position, and patient activities, including those of pregnant mothers. Sibel Health's clinical-grade digital monitoring products are portable and user-friendly, ensuring accuracy and reliability. Additionally, the company offers motion sensor-based chest and limb monitoring devices, along with a comprehensive physiological monitoring platform that incorporates advanced analytics. These innovations are designed to support medical professionals in both clinical care and research applications, particularly within the pharmaceutical and clinical research sectors.
Corner Therapeutics is a biotechnology research company focused on immunotherapy. It specializes in developing technologies that stimulate exceptional memory T cells to achieve lifelong immunity. The company utilizes a versatile dendritic cell hyperactivation platform that induces strong T-cell responses, aiming to provide robust and durable immunity against a wide range of cancers and infectious diseases. By enhancing T-cell activation, Corner Therapeutics seeks to enable healthcare providers to promote lasting immunity and optimize immune regulation.
Pula Advisors they partner with organizations from agriculture to renewable energy.
Ginkgo Bioworks is a biotechnology company based in Boston, Massachusetts, founded in 2008. It specializes in biological engineering, designing and developing custom microbes and organisms for various applications. The company discovers and licenses molecules used in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. Additionally, it offers probiotic bacteria aimed at protecting against infections and creates libraries of molecules for natural product discovery. Ginkgo Bioworks operates primarily in the markets of cultured ingredients, carbon mitigation, probiotics, and biosecurity. The biosecurity segment, which generates the majority of the company's revenue, provides data analytics and related services to organizations across diverse sectors, including food, agriculture, pharmaceuticals, and specialty chemicals.
Antibody Solutions provides antigen design, polyclonal antibody generation, research and drug development for biopharmaceutical companies.
Detect-ION is a cutting-edge deep-tech startup that specializes in the development of sensors and systems for a variety of applications, with a focus on innovation and technological excellence.
Noze is a leader in digital odor perception technology, creating advanced solutions that replicate the human sense of smell. Their sophisticated digital nose utilizes a specialized sensor, developed with NASA technology, to detect and identify odors in various real-world environments. This technology collects and analyzes data through an AI engine, allowing healthcare providers to assess air quality, monitor chemical footprints, and potentially diagnose diseases based on breath-based odor biomarkers. By enabling real-time disease detection and routine health screenings with a single exhale, Noze aims to enhance human health and well-being while improving patient outcomes.
Phase Genomics, Inc. is a biotechnology company based in Seattle, Washington, founded in 2015. The company specializes in developing innovative technology for genome assembly and metagenome deconvolution, focusing on its ProxiMeta Hi-C platform. This platform empowers researchers in various fields, including agriculture, human health, and industrial biology, by enabling the cultivation-independent assembly of bacterial genomes. By exploiting the structure of DNA, Phase Genomics aims to provide scientists with the most complete and accurate genomes and metagenomes possible, facilitating transformative discoveries and advancements in their respective areas of study.
Food Fortification Initiative is a non-profit organization that provides the fortification of industrially milled flour and rice globally.
PhaSER Biomedical is Exploiting the 8HUM mouse, a unique mouse model with multiple utilities in drug discovery, and development.
C16 Biosciences, Inc. is a biotechnology company based in New York, established in 2017, specializing in the production of sustainable alternatives to palm oil through microbiology and fermentation processes. The firm focuses on creating innovative ingredients for food manufacturers, refiners, and consumers, aiming to decarbonize the supply chains of consumer product brands. C16 Biosciences has developed the Palmless™ platform, which features its first biodesigned ingredient, Torula oil—a premium bioactive oil known for its clinically proven benefits for skin and hair health. By leveraging biomanufacturing techniques, the company provides scalable and sustainable options, addressing the demand for environmentally friendly alternatives in the oil and fat market.
ProteinLogic’s ImmiPrint® technology impacts the emerging market for diagnostic, predictive, prognostic and other biomarker applications.
Picnic is an innovative online supermarket that focuses on delivering groceries directly to consumers' homes at competitive prices without any delivery fees. The company's platform enables users to conveniently place orders for fast-moving consumer goods, sourcing products from local suppliers such as bakers and greengrocers. Picnic utilizes electric vehicles for its delivery operations, ensuring an environmentally friendly approach to grocery shopping. By combining technology with a modern take on traditional home delivery services, Picnic aims to provide a seamless and cost-effective shopping experience for its customers.
Radiant Biotherapeutics is an innovative company focused on developing a modular platform for multi-valent and multi-specific therapeutics. This platform aims to advance antibody engineering by producing multi-functional biologics capable of addressing challenging diseases, including cancer, autoimmune disorders, and infectious diseases. By leveraging enhanced binding power and multi-specificity, Radiant Biotherapeutics seeks to create potent therapeutics that have the potential to significantly improve treatment outcomes for patients. The company is committed to delivering transformative therapies through its cutting-edge approach to antibody technology.
Brightseed, Inc. is a biotechnology company based in San Francisco, California, that specializes in the discovery of bioactive compounds in plants to enhance human health. Utilizing its advanced Forager platform, which employs artificial intelligence and machine learning algorithms, Brightseed accelerates the identification and validation of clinically beneficial molecules. This innovative approach enables the company to uncover connections between natural compounds and health outcomes, revealing the potential of bioactives that have previously remained uncharted. By integrating these discoveries back into the food supply chain, Brightseed collaborates with various companies across the consumer health continuum to develop science-backed health solutions aimed at managing chronic diseases and improving overall quality of life. Founded in 2017, Brightseed is committed to exploring the untapped resources of the plant kingdom to address pressing health challenges.
LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS") and Oral Thin Films ("OTF") for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.
Molecular Loop is a biotechnology company focused on DNA sequencing. It offers a unique approach to sequencing through its Molecular Loop targeting technology, which eliminates the need for a separate library preparation process. The company's method involves designing amplicons that tile across each target on both strands, providing sequence data with minimal additional work and cost. Molecular Loop also provides custom assays tailored to user specifications, alongside expanded and customizable carrier screening panels and SARS-CoV-2 research panels. This enables healthcare professionals and researchers to access efficient systems for production-scale targeted sequencing applications.
Ginkgo Bioworks is a biotechnology company based in Boston, Massachusetts, founded in 2008. It specializes in biological engineering, designing and developing custom microbes and organisms for various applications. The company discovers and licenses molecules used in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. Additionally, it offers probiotic bacteria aimed at protecting against infections and creates libraries of molecules for natural product discovery. Ginkgo Bioworks operates primarily in the markets of cultured ingredients, carbon mitigation, probiotics, and biosecurity. The biosecurity segment, which generates the majority of the company's revenue, provides data analytics and related services to organizations across diverse sectors, including food, agriculture, pharmaceuticals, and specialty chemicals.
Naobios is able to help with the development and optimization of processes for the generation of your live vaccine product. If you want would contact them please contact them via phone call or email.
VitriVax is a biotechnology startup based in Boulder, Colorado, focused on developing an innovative vaccine formulation platform. The company utilizes its proprietary atomic layering thermostable antigen and adjuvant (ALTA) technology to create vaccines that are more effective, affordable, and accessible worldwide. This technology addresses the challenges associated with vaccine stability and administration by enabling the development of thermostable, single-shot vaccines that can effectively incorporate both prime and booster doses. VitriVax's advancements in vaccine formulation aim to eliminate barriers to global vaccination, ultimately enhancing immune responses for a broad range of medical indications. The company has received significant funding, including over $5 million from various sources such as the National Institutes of Health, the National Science Foundation, and the Bill and Melinda Gates Foundation, to support its mission.
LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS") and Oral Thin Films ("OTF") for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.
Kyron Learning is an EdTech company that provides equitable access to one-on-one education.
Micron Biomedical is a clinical-stage biopharmaceutical company established in 2014 and located in Atlanta, Georgia. The company focuses on developing microneedle patches specifically for vaccines, including those for influenza and polio. Its innovative microneedle technology aims to improve protective and therapeutic effects while enhancing patient compliance and simplifying the administration process. By leveraging this technology, Micron Biomedical seeks to facilitate the development of effective vaccines, addressing important public health needs.
Osmo gives computers a sense of smell that improves the health and well-being of human life. Osmo brings together frontier AI and olfactory science to tackle a historic challenge. While they are initially focused on the intricate world of fragrance, their ultimate objective is to enhance the health and well-being of human life through the sense of smell.
BiomEdit is an innovation company focused on developing novel probiotics and microbiome-derived bioactives to enhance animal health. The company aims to tackle significant challenges in animal agriculture and food security by harnessing the potential of the microbiome. Utilizing a unique platform that incorporates high-throughput sequencing and data analytics, BiomEdit rapidly discovers and screens new probiotic species and bioactive molecules. These innovations can be engineered for improved thermostability, increased production of beneficial metabolites, and expression of immune-modulating proteins. By creating next-generation products that promote animal health without relying on antibiotics, BiomEdit addresses critical needs in livestock production and disease management.
Axmed is a business focuses on LMICs and strengthens the purchasing power of these markets to ensure the supply of cost-effective, high-quality medicines. We partner exclusively with authorized, high-quality pharmaceutical companies and certified caregivers to accelerate access to medicines.
Tianjin CanSino Biotech Inc. is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices.
Salient creates a weather intelligence platform that combines novel ocean and land-surface data with machine learning and climate expertise to provide accurate subseasonal-to-seasonal (S2S) weather forecasts 2 to 52 weeks ahead. Salient's tools sift through large datasets to identify complex climate system relationships in order to provide accurate forecasts used in agriculture, energy, finance, supply chain, and other industries. Salient utilizes scientific knowledge to assist individuals and organizations in better understanding and preparing for the increasing volatility of climate change.
STRM.BIO is a biotechnology company focused on enhancing gene therapy delivery through the use of extracellular vesicles (EVs). These natural carriers, which transport nucleic acids and proteins, offer innate targeting capabilities and can be mass-produced efficiently. By leveraging EVs, STRM.BIO aims to create a new class of therapeutics that not only introduces novel treatments but also improves the effectiveness of existing therapies. The company's approach seeks to simplify and enhance the safety of gene therapy delivery directly to patients, fulfilling the potential of this innovative medical field.
Scentian Bio is a developer of innovative biosensor devices that integrate insect biology with nanotechnology to revolutionize sensing applications. The company's technology leverages insect odorant receptors to create biosensors for commercial use in the medical and food industries. By employing machine learning, these devices can detect volatile organic compounds, such as off-notes in food and beverages, as well as identify fraud and adulterants in raw materials. Scentian Bio aims to provide users with advanced sensing solutions that harness the power of nature, making it easier to understand and respond to complex chemical signals.
AN2 Therapeutics, Inc. is a biopharmaceutical company based in Menlo Park, California, founded in 2017. The company is dedicated to the research, development, and commercialization of innovative medicines aimed at addressing infectious diseases. AN2 Therapeutics is focused on developing epetraborole, a once-daily oral treatment for patients suffering from chronic non-tuberculous mycobacterial lung disease, which represents a significant unmet medical need. Additionally, the company has established a strategic partnership with Brii Biosciences to enhance its development efforts.
Vietnam faces a disconnect between its educational priorities and the demand for skilled employees. While Vietnamese students perform well on standard academic tests, employers consistently report that students lack the skills needed to excel, as reflected in the high underemployment rate of college graduates.
Nuoc.Solutions aims to create and foster innovative, sustainable, and efficient solutions to pressing water problems in Vietnam.
The American University of Beirut (AUB), established in 1866 and formerly known as Syrian Protestant College, is a prominent educational institution located in Beirut, Lebanon. Adhering to the American liberal arts model, AUB emphasizes a teaching-centered approach to research and education. It offers over 120 academic programs across six faculties: Agricultural and Food Sciences, Arts and Sciences, Engineering and Architecture, Health Sciences, Medicine, and Business Management. The university serves approximately 8,000 students, supported by around 800 instructional faculty, with a balanced gender ratio of 50 percent male and 50 percent female. AUB fosters an environment that encourages freedom of thought and expression, aiming to cultivate graduates equipped with critical thinking skills, personal integrity, and civic responsibility. The institution is accredited by the Commission on Higher Education of the Middle States Association of Colleges and Schools in the United States, having received its initial accreditation in 2004. Instruction is primarily conducted in English, except for specific language courses.
The Lahore University of Management Sciences (LUMS) is a national university, established by sponsors belonging to the country’s leading private and public sector corporations. The goal of the sponsors is to develop an institution, which would provide rigorous academic and intellectual training and a viable alternative to education comparable to leading universities across the world.
EHA Clinics is dedicated to providing accessible, effective, and affordable healthcare services. The organization offers a comprehensive healthcare network that includes routine medical care, laboratory services, pharmacy, optometry, dental care, urgent care, and specialist consultations. EHA Clinics ensures that members have round-the-clock access to healthcare through various channels, including physical locations, telehealth virtual visits, and home care services. By leveraging technology and a skilled team, EHA Clinics aims to enhance the healthcare experience, improve patient outcomes, and offer competitive pricing for individual, family, and business members.
Bactolife is a company dedicated to addressing the global challenge of antimicrobial resistance through innovative solutions. Its proprietary Binding Protein ingredients are designed to strengthen the gut microbiome and minimize the risk of gastrointestinal infections in both humans and animals. By focusing on neutralizing harmful pathogens and their toxins while preserving beneficial microbes, Bactolife aims to enhance gut health and reduce reliance on traditional antimicrobials. The company's approach emphasizes the modulation of the gut microbiome to improve overall health outcomes, making a significant contribution to the fight against antimicrobial resistance. Through its developments, Bactolife seeks to empower individuals and communities worldwide in maintaining better health.
A-Alpha Bio, Inc. is a biotechnology company based in Seattle, Washington, established in 2017. The company specializes in synthetic biology, offering a platform known as AlphaSeq, which assists pharmaceutical companies in the development of drugs that interact with multiple targets. A-Alpha Bio provides cell-based tools for high-throughput and quantitative measurements of protein interactions, facilitating target discovery, library screening, and preclinical drug characterization. Its proprietary technology enables the mapping of protein-protein interactions at a large scale, allowing for the identification and quantification of interactions among thousands of protein pairs simultaneously. By delivering detailed maps of these interactions, A-Alpha Bio helps researchers identify potential drug targets and understand disease mechanisms, thereby streamlining the therapeutic discovery process and improving the efficiency of drug development. The company comprises a team of experts in synthetic biology, structural biology, and next-generation sequencing, focused on overcoming challenges in the drug development pipeline.
Aptitude Medical Systems provides the next generation of diagnostic testing, delivering lab-quality results quickly and easily wherever people need them. The company's mission is to combine the sensitivity and specificity of lab-based PCR tests with the cost-effectiveness and scalability of antigen tests. The company has developed proprietary synthetic molecules, known as aptamers, which enhance molecular recognition capabilities beyond traditional antibody technologies. This innovation enables early detection and treatment of diseases such as cancer, autoimmune disorders, and heart disease.
Co-Diagnostics is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.
Soapbox Labs specializes in child-specific speech recognition technology that accurately captures the unique speech patterns and idiosyncrasies of children. The company's innovative voice engine is designed to support a variety of applications, including toys, gaming, robotics, augmented and virtual reality, and educational tools focused on literacy and language learning. By providing immediate and precise feedback, Soapbox Labs enhances the learning experience for children across different accents, dialects, and developmental stages. Their technology is fully compliant with COPPA and GDPR regulations, ensuring a safe environment for young users. With solutions available both online and offline, Soapbox Labs aims to foster effective voice-enabled interactions for children.
Aphea.Bio focuses on developing innovative agricultural products aimed at enhancing crop health and yields. The company specializes in creating next-generation biopesticides derived from natural microorganisms, which serve as sustainable alternatives to traditional chemical pesticides facing regulatory challenges. Additionally, Aphea.Bio produces biostimulants that promote crop growth by enhancing nutrient uptake from the soil. Utilizing proprietary technologies, the company is dedicated to discovering new biocontrol and biostimulant products that help farmers sustainably manage fungal diseases, pests, and weeds, ultimately improving crop productivity and environmental health.
Myna Mahila Foundation is a non-governmental organization that provides employment and skills to women in slum neighborhoods.
Latham BioPharm Group (LBG) provides the insight, knowledge, and network to unite teams and technologies in the Life Sciences. They provide the depth of expertise necessary to advance your programs, by providing a range of life science services including business development, program management, CMC, quality, regulatory, and strategic consulting with proven experience in biodefense/pandemic response and strategic product development. Our team has an average of over 20 years’ experience and many have served as senior executives at companies ranging from start-ups to Fortune 200 companies. A number of us have also held senior level positions within the US government. For over twenty years, they have helped clients identify, evaluate, fund, manage, and monetize opportunities in a wide variety of business segments, generating over $1 billion in government funding and over $100 million in licensing fees and investments. On the front end, they assist clients in evaluating critical business decisions and connecting with the target markets to assess opportunities with our Strategy and Portfolio Analysis, Market Research, and Commercial and Government Asset Analysis offerings. They then assist in finding and securing funding through our Business Development and Non-Dilutive Funding Services. Once funded, they drive successful advancement to a targeted value-inflection point through our Program Management and Product Development Team services.
Lectrolyst it, creating novel ways to use electricity to achieve chemical changes. From benchtop synthesis to chemical processing facilities, their technologies offer on-site, scalable solutions to match customers' industrial demands. uses electricity to create fine chemical components from waste CO2 and renewable feedstocks.
Aegis Life is a biotechnology company focused on advancing nucleic acid delivery technology, specifically through its proprietary platform known as fusogenix PLV. This technology, developed over two decades, is designed to facilitate the rapid development and commercialization of vaccines and therapeutics aimed at preventing and treating infectious diseases. Aegis Life's innovative approach supports the pharmaceutical industry in accelerating the discovery, clinical development, and manufacturing processes for vaccines and treatments, particularly in response to emerging health threats such as COVID-19.
The Council for Scientific and Industrial Research, commonly known as the CSIR, is a world-class African research and development organisation established through an Act of Parliament in 1945. The CSIR undertakes directed, multidisciplinary research and technological innovation that contributes to the improved quality of life of South Africans. The organisation plays a key role in supporting government’s programmes through directed research that is aligned with the country’s priorities, the organisation’s mandate and its science, engineering and technology competences. Key issues that the CSIR seeks to address through various interventions include: creating a vibrant economy and employment opportunities; building a capable state that is able to consistently deliver high-quality services for all South Africans; contributing to the development of economic and social infrastructure like transport, energy, water resources and ICT networks. The CSIR’s shareholder is the South African Parliament, held in proxy by the Minister of Science and Technology.
Hyperfine is a medical device company that developed Swoop, the first FDA-cleared point-of-care MRI system designed to enhance patient access to diagnostic imaging. Swoop operates at a lower magnetic field strength than traditional MRI machines, producing high-quality images quickly and efficiently. This portable system can be easily wheeled to a patient's bedside, plugged into a standard electrical outlet, and operated via an iPad, making it suitable for various clinical environments such as emergency departments and intensive care units. Hyperfine generates revenue through the sale of MRI devices and service sales, which include subscriptions for bundled devices, maintenance, and software. By providing rapid imaging capabilities at a fraction of the cost of conventional MRIs, Hyperfine aims to facilitate timely diagnoses and treatments for patients, regardless of their location or resources.
The Medicines for All Institute, operating under the auspices of the Virginia Commonwealth University School of Engineering.